NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
29/03/2024
Voltar para busca
Dado oficial do USPTO
GENFIT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
23/05/2025
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
31/01/2002
Data de registro
27/07/2004
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/03/2024
Última transação
23/05/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
1
Tipo de titular
03
Localização do titular
Loos, FR
Examinador
MCMORROW, RONALD
Unidade examinadora
L50
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
GENFIT
Representantes
Ronald M. Kachmarik Cooper Legal Group LLC
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for use in the treatment of cardiovascular diseasesdermatological diseasesmetabolic disordersinflammatory disordersskin and mucosal disordersdisorders in the central nervous systeminfectionscancers and oncological disordersimmunodeficiency and immunologic disordersasthmaallergieslipidic disordersobesity and diabetes; veterinary pharmaceutical preparations for use in the treatment of cardiovascular diseasesdermatological diseasesmetabolic disordersinflammatory disordersskin and mucosal disordersdisorders in the central nervous systemcancersoncological disordersimmunodeficiency and immunologic disordersasthmaallergieslipidic disordersobesity and diabetes; sanitary preparations for diagnosis and for acute and chronic careantibioticantibacterialantiviral and antifungal agents for elimination or reduction of germsbacteriaviruses and fungi; chemical preparations for medicalpharmaceutical or veterinary diagnostic use; enzymatic preparations for medicalpharmaceutical or veterinary use; biological preparationsantibodies and fragments of antibodies for laboratoriesdiagnosticsanalytics for human and veterinary medical diagnostic use; pharmaceutical preparations for the treatment of skin conditionsmedicated skin care preparation for pharmaceutical use; medicated sunburn preventing productscreamsoilslotionsgelsfor pharmaceutical use; slimming medical preparations; cultures of microorganisms for medicalpharmaceutical and veterinary use; media for bacteriological cultures; nutrients for use in medicalpharmaceutical and veterinary research; cell preparations for medicalpharmaceutical or veterinary usein particular for gene therapy and cell therapy; kits consisting primarily of culture mediaculture boxesculture additivesdiagnostic reagents for the preparation of cells or for the selection of biologically active compounds for medicalpharmaceutical or veterinary laboratory testingfor medical or veterinary diagnostic use; diagnostic and biological preparations and cultures of microorganisms and cells for clinical or medical laboratory use; reagents for medicalveterinary and diagnostic usediagnosis productsreagents for medical or veterinary use; chemical and biological reagents for clinical or medical laboratory use; diagnostic preparations for clinical or medical laboratory use; diagnosis reagents for medicalveterinary use and in vitro use in biochemistryclinical chemistry and microbiology; dietetic substancesdietary supplements and food supplements for medical use; dietetic foodstuffs adapted for medical use
Classe 42
Pharmaceutical research and development of new drug products for others; scientificbiological and medical research in the fields of pharmacologyanalytical chemistrybiochemistryimmunologygeneticmedicinal chemistrydrug development of new drug products for others; scientificbiological and medical research in the field of pharmacologyanalytical chemistrybiological and medical research in the field of pharmacologyanalytical chemistrybiochemistryimmunologygeneticmedicinal chemistrydrug developmentbiotechnologymicrobiology and molecular biologychemicalbiochemical and biotechnological analysis; basic and applied scientific research; technical researchnamely screening and selection of molecules; validation of biological targets; development and validation of biological testscell testsgenetic testsidentifyingcharacterizingvalidatingdevelopment biologically active molecules through the se of functional genomics; analysis of biological substances in biological fluids; technical consultation in the field of pharmaceuticals; legal services in the field of scientific researchmedical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific researchmedical sciences and intellectual property rights; patent agency and licensing; computer programming in the field of scientific research and for the pharmaceutical industry; surveying and engineering; chemical analysis in the field of pharmacology; technical consultation in the field of pharmacology; consultationnot connected with the conduct of businessin the fields of scientific research and therapy; research and development of new pharmaceutical products for third parties; providing an online electronic computer database in the field of scientific information
Classe 44
Providing an online electronic computer database in the field of medical and pharmaceutical information
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
29/03/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
29/03/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
29/03/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
06/11/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
27/07/2023
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
16/09/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
16/09/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
16/09/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/08/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
25/07/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
13/08/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/08/2010
E815
TEAS SECTION 8 & 15 RECEIVED
22/07/2010
CORV
REVIEW OF CORRESPONDENCE COMPLETE
20/02/2009
PAPER RECEIVED
02/02/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
27/07/2004
PAPER RECEIVED
10/05/2004
PUBO
PUBLISHED FOR OPPOSITION
04/05/2004
NPUB
NOTICE OF PUBLICATION
14/04/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2003
PAPER RECEIVED
20/10/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/10/2003
CNRT
NON-FINAL ACTION MAILED
27/08/2003
CFIT
CASE FILE IN TICRS
16/07/2003
1.BD
Sec. 1(B) CLAIM DELETED
09/07/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2003
PAPER RECEIVED
09/07/2003
CNSL
LETTER OF SUSPENSION MAILED
10/01/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/11/2002
PAPER RECEIVED
13/11/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/11/2002
DOCK
ASSIGNED TO EXAMINER
17/10/2002
CNRT
NON-FINAL ACTION MAILED
08/05/2002
PAPER RECEIVED
29/04/2002
DOCK
ASSIGNED TO EXAMINER
19/04/2002
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GENFIT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.